PEP — PepsiCo, Inc.

Sentiment as of 2026-10-08 is clearly negative: PEP is down 20.85% over six months, 9.96% over one month and 9.57% over three months, and has markedly underperformed Coca-Cola and the broader market. The downgrade wave around the Q3 print (JPMorgan to Neutral at $138, Deutsche Bank to Hold at $138, UBS to $145, Barclays to $133, Evercore ISI to $135) confirms the sell side is resetting expectations, and the consensus rating sits at Hold with a $145.25 average target. The bear case is simple and credible — North America snacks volumes have stalled after years of cumulative price hikes, GLP-1 adoption is a long-term question mark, and the company just cut its own EPS growth outlook. The only meaningful support is valuation and income: a 4.2% FMP-computed dividend yield (~4.7–4.8% per the brief after the recent 4% payout hike), a 15.6x trailing P/E versus a 26.2x five-year average, and an RSI of 27.0 that flags an oversold condition.

The consolidated trend is better than the narrative suggests, but the segment mix is the problem. Revenue growth has reaccelerated sharply — Q1 2025 was -1.81% YoY, Q2 2025 +1.00%, Q3 2025 +2.65%, then Q4 2025 +5.61%, Q1 2026 +8.50%, Q2 2026 +6.40% and Q3 2026 +5.59% — though the brief attributes this largely to price/mix and international (+8% organic), not North America volume. Consolidated operating margin is genuinely expanding YoY: 16.86% in Q3 2026 vs. 15.47% in Q3 2025, 16.64% vs. 16.06% in Q2, 16.53% vs. 14.41% in Q1, and 12.12% vs. 8.10% in Q4 2025. Reported net income and EPS comparisons are flattered by charges: Q2 2025 EPS was only $0.92 and Q4 2024 EPS only $1.11, so the big YoY EPS jumps (Q2 2026 $2.18, Q3 2026 $2.23 vs. $1.90) are partly base-effect, not pure momentum. Free cash flow is the quiet strength — Q3 2026 generated $5.585B operating cash flow and $4.319B FCF vs. $4.472B/$3.480B a year earlier, taking TTM FCF to roughly $10.1B, and the accruals ratio of -2.27% (cash exceeding reported profit) is a healthy earnings-quality signal. The genuine deterioration is narrow but important: Frito-Lay North America core operating profit fell 12% YoY, and that is what drove the guidance cut. Verdict: consolidated results are stable-to-inflecting upward, one key segment is deteriorating, and forward guidance — not trailing financials — is the source of the negativity.

As of 2026-10-08, PEP traded at $124.58, or 15.63x trailing EPS of $8.013 — roughly 40% below its own five-year average P/E of 26.18x — and about 14.6x the FY2027 consensus EPS of $8.544. Price/sales is 1.73x versus a 2.57x five-year average, PEG is 0.305, and EV/EBITDA is 11.8x. The 7.62x price/book looks extreme but is an artifact of buybacks shrinking equity to $22.3B against $112.0B of assets (ROE 40.4%, ROIC 13.3%). On absolute history this is cheap, and the 4.2% yield (FMP) with ~1.4x FCF coverage is well supported. The honest caveat: part of the de-rating is deserved, because the growth algorithm reset from 5–7% core EPS growth to 2.5–3.5%. This is a cheap staple, not a mispriced growth stock — a re-rating to even 18x on unchanged estimates would imply ~$154, but the market is unlikely to pay a premium multiple for a company with flat North American volumes.

At $124.58 as of 2026-10-08, the stock is trading at ~14.6x FY2027 consensus EPS of $8.544 while the sell-side average target sits at $145.25 and the recent-action average at $149.15 — meaning the market is discounting materially more pessimism than the guidance cut alone justifies. Run the math both ways: if North America volumes stabilize, cost cuts land, and PEP holds $8.54 in EPS at a 16.5x multiple, fair value is roughly $141; if Frito-Lay volumes keep sliding and estimates drift toward $8.20–8.30 at 15x, you get $123–$125 — essentially today's price. In other words, the bear case is already largely in the tape, but so is the base case, and the upside requires an operational inflection that has not yet appeared in the data. This is a stock where you are paid (4.2%+ yield) to wait, but you are not buying an obvious earnings-momentum story.

As of 2026-10-08, the technical setup is unambiguously weak: RSI-14 at 27.0 puts PEP in oversold territory, and the stock is 3.69% below its 20-day SMA, 8.15% below its 50-day SMA and 15.06% below its 200-day SMA — a clean, persistent downtrend, not a range. The close of $124.58 is barely above the 52-week low of $123.47, and the six-month return of -20.85% versus -0.75% for the last week shows the selling has at least decelerated. Timing implication: oversold bounces are common from RSI levels near 27, but there is no evidence of basing yet; a genuine trend reversal would require the price to reclaim the 20-day and then the 50-day SMA. Buying here is a mean-reversion/income bet, not a momentum entry, and anyone doing so should be prepared for further downside toward the low-$120s.

• Consumer staples demand fatigue: after several years of cumulative price increases, value-conscious shoppers are trading down and resisting further price, which is showing up as stalled North America snack volumes while private label gains share.
• Input cost inflation: elevated raw material, fuel and labor costs continue to squeeze margins, most acutely in the domestic snack division where volume leverage has disappeared.
• GLP-1 weight-loss drug adoption: a genuine long-term secular headwind to snacking and sugary beverage volumes, which PepsiCo is partially offsetting via healthier portfolio moves such as the Poppi prebiotic soda acquisition.
• Rates and the bond-proxy trade: a ~4.2% dividend yield competes directly with fixed income; a lower-rate environment would make PEP's yield and balance-sheet quality relatively more attractive, while higher-for-longer rates keep pressure on staples multiples.
• Sector rotation and relative performance: capital has favored higher-growth areas and Coca-Cola over PEP, and that relative de-rating can persist independent of PepsiCo's own results.
• FX and international mix: with North America weak, the international business (+8% organic) is now the growth engine, which increases sensitivity to currency moves and emerging-market demand.

• North America volume recovery: whether holiday-season promotions, the Alani Nu distribution partnership and Poppi scaling can restart Frito-Lay volume growth — the single biggest swing factor for the thesis.
• Cost-cutting execution: management has promised operational efficiency savings to protect margins; concrete quantification and a timeline would be a positive re-rating trigger.
• Q4 2026 results (next print estimated 2026-11-25, with the formal Q4 release typically following in early February 2027): confirmation or reversal of the trimmed 2.5–3.5% core EPS growth guidance.
• International momentum: continuation of the +8% organic international growth that is currently offsetting domestic weakness.
• Capital returns: the recent 4% dividend hike, a 4.2%+ yield and ongoing buybacks provide a valuation floor if fundamentals merely stabilize.
• Multiple normalization: at 15.6x trailing versus a 26.2x five-year average, even a partial re-rating toward the high-teens on stable earnings would be worth roughly $145–155.

• Further guidance cuts: FY26 core EPS growth expectations have already been cut from the low end of 5–7% to 2.5–3.5%; another reduction would likely break the 52-week low decisively.
• Frito-Lay North America deterioration: core operating profit fell 12% YoY last quarter, and continued volume/share loss to private label would undermine the company's highest-margin profit pool.
• Balance sheet leverage: debt-to-equity of 2.33, $42.7B of long-term debt against $10.7B of cash, and a current ratio just below 1.0 (0.943) leave less flexibility than the 'defensive staple' label implies.
• GLP-1 structural risk: slower-than-expected adaptation of the portfolio to health trends could cap long-term volume growth.
• Value trap risk: a 15.6x P/E and 4.2% yield are only attractive if earnings stabilize; if growth settles structurally at low-single-digits, the multiple may simply stay compressed.
• Negative sell-side momentum: a Hold consensus with recent downgrades to $133–$145 targets means estimate revisions are still trending down, which historically pressures the share price.

PepsiCo as of 2026-10-08 is a decent, honest income holding and a mediocre growth investment — not a compelling buy at this exact moment. The strengths are real: $10.1B of TTM free cash flow comfortably covers the dividend, TTM operating margins are actually expanding YoY (16.86% in Q3 2026 vs. 15.47%), international is growing 8%, and at 15.6x trailing / ~14.6x forward the stock is cheap against its own 26.2x five-year average with an oversold RSI of 27.0. The problem is equally real: the domestic snacks engine is losing volume and profit, and management just cut guidance, so there's no visible catalyst to force a re-rating. I'd treat PEP as a hold-and-collect-the-dividend name rather than a place to add aggressively, and I'd want to see either a Frito-Lay volume inflection or the stock reclaim its 50-day SMA before calling a bottom.

Primary method: a 16.5x forward P/E applied to FY2027 consensus EPS of $8.544 yields ~$141, with the multiple justified as a deliberate discount to PEP's own 26.2x five-year average P/E (which was inflated by the 2023–24 premium era) and consistent with a staple now growing core EPS 2.5–3.5% rather than 5–7%; major downside is already reflected because this sits only modestly above the current 14.6x forward multiple. Cross-check: a simplified DCF on TTM free cash flow of $10.1B growing ~3% with a 7.5% WACC and 2.5% terminal growth, less ~$32.0B net debt and ~1.366B shares, produces roughly $132, bracketing the multiple-based figure; I weighted the earnings-multiple approach slightly higher given PepsiCo's highly predictable staple cash flows, landing on $141.